Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer

Clinical trial NCT07195227 · RECRUITING

Trial details

NCT number: NCT07195227
Sponsor: MedSIR
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hormon Receptor Positive Breast Cancer Breast Cancer

Start date: 2026-03-24
Primary completion: 2028-02-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.